» Articles » PMID: 3299053

Definition of Regions in Human C-myc That Are Involved in Transformation and Nuclear Localization

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 1987 May 1
PMID 3299053
Citations 185
Authors
Affiliations
Soon will be listed here.
Abstract

To study the relationship between the primary structure of the c-myc protein and some of its functional properties, we made in-frame insertion and deletion mutants of the normal human c-myc coding domain that was expressed from a retroviral promoter-enhancer. We assessed the effects of these mutations on the ability of c-myc protein to cotransform normal rat embryo cells with a mutant ras gene, induce foci in a Rat-1-derived cell line (Rat-1a), and localize in nuclei. Using the cotransformation assay, we found two regions of the protein (amino acids 105 to 143 and 321 to 439) where integrity was critical: one region (amino acids 1 to 104) that tolerated insertion and small deletion mutations, but not large deletions, and another region (amino acids 144) to 320) that was largely dispensable. Comparison with regions that were important for transformation of Rat-1a cells revealed that some are essential for both activities, but others are important for only one or the other, suggesting that the two assays require different properties of the c-myc protein. Deletion of each of three regions of the c-myc protein (amino acids 106 to 143, 320 to 368, and 370 to 412) resulted in partial cytoplasmic localization, as determined by immunofluorescence or immunoprecipitation following subcellular fractionation. Some abnormally located proteins retained transforming activity; most proteins lacking transforming activity appeared to be normally located.

Citing Articles

Myc 9aaTAD activation domain binds to mediator of transcription with superior high affinity.

Knight A, Houser J, Otasevic T, Juran V, Vybihal V, Smrcka M Mol Med. 2024; 30(1):211.

PMID: 39538178 PMC: 11558822. DOI: 10.1186/s10020-024-00896-7.


MYC acetylated lysine residues drive oncogenic cell transformation and regulate select genetic programs for cell adhesion-independent growth and survival.

Hurd M, Pino J, Jang K, Allevato M, Vorontchikhina M, Ichikawa W Genes Dev. 2023; 37(19-20):865-882.

PMID: 37852796 PMC: 10691474. DOI: 10.1101/gad.350736.123.


Cellular redox homeostasis maintained by malic enzyme 2 is essential for MYC-driven T cell lymphomagenesis.

Li W, Kou J, Zhang Z, Li H, Li L, Du W Proc Natl Acad Sci U S A. 2023; 120(23):e2217869120.

PMID: 37253016 PMC: 10266009. DOI: 10.1073/pnas.2217869120.


MTBP and MYC: A Dynamic Duo in Proliferation, Cancer, and Aging.

Grieb B, Eischen C Biology (Basel). 2022; 11(6).

PMID: 35741402 PMC: 9219613. DOI: 10.3390/biology11060881.


Regulation of Nucleolar Activity by MYC.

Brown I, Lafita-Navarro M, Conacci-Sorrell M Cells. 2022; 11(3).

PMID: 35159381 PMC: 8834138. DOI: 10.3390/cells11030574.


References
1.
Watt R, Nishikura K, SORRENTINO J, Croce C, Rovera G . The structure and nucleotide sequence of the 5' end of the human c-myc oncogene. Proc Natl Acad Sci U S A. 1983; 80(20):6307-11. PMC: 394286. DOI: 10.1073/pnas.80.20.6307. View

2.
Sarid J, Halazonetis T, Murphy W, Leder P . Evolutionarily conserved regions of the human c-myc protein can be uncoupled from transforming activity. Proc Natl Acad Sci U S A. 1987; 84(1):170-3. PMC: 304164. DOI: 10.1073/pnas.84.1.170. View

3.
Chirgwin J, Przybyla A, MacDonald R, Rutter W . Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979; 18(24):5294-9. DOI: 10.1021/bi00591a005. View

4.
Auffray C, Rougeon F . Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem. 1980; 107(2):303-14. DOI: 10.1111/j.1432-1033.1980.tb06030.x. View

5.
Gluzman Y . SV40-transformed simian cells support the replication of early SV40 mutants. Cell. 1981; 23(1):175-82. DOI: 10.1016/0092-8674(81)90282-8. View